Liver involvement in hemophagocytic syndrome;Atteinte hépatique au cours du syndrome d'activation macrophagique

Gastroenterologie Clinique et Biologique

Volumn 31, Issue 11, 2007, Pages 959-966

  Larroche, Claire ^a,d   Ziol, Marianne ^b   Zidi, Sémia ^c   Dhote, Robin ^a   Roulot, Dominique ^a  

^a AVICENNE HOSPITAL   (France)

^b HÔPITAL JEAN VERDIER   (France)

^c Hopital Leon Binet   (France)

^d UNIVERSITÉ PARIS 13   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; BASILIXIMAB; CYCLOSPORIN; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN; LIVER ENZYME; METHOTREXATE; TUMOR NECROSIS FACTOR ANTIBODY;

ANEMIA; CHOLESTASIS; CYTOPENIA; ENZYME BLOOD LEVEL; FEVER; HEMOPHAGOCYTIC SYNDROME; HEPATOMEGALY; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LEUKOPENIA; LIVER BIOPSY; LIVER DYSFUNCTION; LYMPHADENOPATHY; NEUROLOGIC DISEASE; PLASMAPHERESIS; PROGNOSIS; REVIEW; SPLENOMEGALY; STEM CELL TRANSPLANTATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 38149070236     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0399-8320(07)78305-7     Document Type: Article

References (55)

1. Imashuku S. Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997;66:135-51.
2. Henter JI, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004;50:157-74.
3. Menasche G, Feldmann J, Fischer A, de Saint Basile G. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Immunol Rev 2005;203:165-79.
4. Janka G, Zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program 2005:82-8.
5. Risdall RJ, McKenna RW, Nesbit ME, Krivit W, Balfour HH Jr, Simmons RL, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979;44:993-1002.
6. Reiner AP, Spivak JL. Hematophagic histiocytosis. Medicine 1988;67:369-88.
7. Albert A, Azgui Z, Buisine J, Ciaudo M, Fenneteau O, Fillola G, et al. Macrophage activation syndromes. Nouv Rev Fr Hematol 1992;34:435-41.
8. Wong KF, Chan JK. Reactive hemophagocytic syndrome-a clinicopathologic study of 40 patients in an Oriental population. Am J Med 1992;93:177-80.
9. Tiab M, Mechinaud F, Hamidou M, Gaillard F, Raffi F, Harousseau JL. Syndromes hémophagocytaires. Une série de 23 observations. Ann Med Interne 1996;147:138-44.
10. Sailler L, Duchayne E, Marchou B, Brousset P, Pris J, Massip P, et al. Aspects étiologiques des hémophagocytoses réactionnelles: étude rétrospective chez 99 patients. Rev Med Interne 1997;18:855-64.
11. Tsuda H. Hemophagocytic syndrome in children and adults. Int J Hematol 1997;65:215-26.
12. Kaito K, Kobayashi M, Katayama T, Otsubo H, Ogasawara Y, Sekita T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol 1997;59:247-53.
13. De Kerguenec C, Hillaire S, Molinie V, Gardin C, Degott C, Erlinger S, et al. Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 2001;96:852-7.
14. Emmenegger U, Reimers A, Frey U, Fux CH, Bihl F, Semela D, et al. Reactive macrophage activation syndrome: a simple screening strategy and its potential in early treatment initiation. Swiss Med Wkly 2002;132:230-6.
15. Omagari K, Ashida R, Oh-I H, Minamino Y, Sasaki O, Ozono Y, et al. Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. Am J Med Sci 1997;314:403-7.
16. Parizhskaya M, Reyes J, Jaffe R. Hemophagocytic syndrome presenting as acute hepatic failure in two infants: clinical overlap with neonatal hemochromatosis. Pediatr Dev Pathol 1999;2:360-6.
17. Senger C, Gonzalez-Crussi F. Histiocytic-phagocytic infiltrates in the liver of an infant: a case clinically simulating perinatal hemochromatosis. J Pediatr Gastroenterol Nutr 1999;29:215-20.
18. Nouette-Gaulain K, Rossi H, Neau-Cransac M, Quinart A, Revel P, Sztark F. Insuffisance hépatique aigue sévère et syndrome d'activation macrophagique : cause ou conséquence ? Ann Fr Anesth Reanim 2004;23:349-52.
19. Kapelari K, Fruehwirth M, Heitger A, Konigsrainer A, Margreiter R, Simma B, et al. Loss of intrahepatic bile ducts: an important feature of familial hemophagocytic lymphohistiocytosis. Virchows Arch 2005;446:619-25.
20. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 1997;103:114-20.
21. Nahum E, Ben-Ari J, Stain J, Schonfeld T. Hemophagocytic lymphohistiocytic syndrome: unrecognized cause of multiple organ failure. Pediatr Crit Care Med 2000;1:51-4.
22. Gauvin F, Toledano B, Champagne J, Lacroix J. Reactive hemophagocytic syndrome presenting as a component of multiple organ dysfunction syndrome. Crit Care Med 2000;28:3341-5.
23. Matthes-Martin S, Peters C, Konigsrainer A, Fritsch G, Lion T, Heitger A, et al. Successful stem cell transplantation following orthotopic liver transplantation from the same haploidentical family donor in a girl with hemophagocytic lymphohistiocytosis. Blood 2000;96:3997-9.
24. Song KS, Sung HJ. Effect of plasma exchange on the circulating IL-6 levels in a patient with fatal hemophagocytic syndrome associated with bile ductopenia. Ther Apher Dial 2006;10:87-9.
25. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.
26. Karras A, Hermine O. Syndrome d'activation macrophagique. Rev Med Interne 2002;23:768-78.
27. Dhote R, Simon J, Papo T, Detournay B, Sailler L, Andre MH, et al. Reactive hemophagocytic syndrome in adult systemic disease: report of twenty-six cases and literature review. Arthritis Rheum 2003;49:633-9.
28. Henter JI, Arico M, Elinder G, Imashuku S, Janka G. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am 1998;12:417-33.
29. Marton PF. Erythrophagocytosis in the human bone marrow as disclosed by iliacal bone biopsies. Scand J Haematol 1975;14:153-9.
30. Tsui WM, Wong KF, Tse CC. Liver changes in reactive haemophagocytic syndrome. Liver 1992;12:363-7.
31. Ost A, Nilsson-Ardnor S, Henter JI. Autopsy findings in 27 children with haemophagocytic lymphohistiocytosis. Histopathology 1998;32:310-6.
32. Jaffe R. Liver involvement in the histiocytic disorders of childhood. Pediatr Dev Pathol 2004;7:214-25.
33. Kikuchi K, Miyakawa H, Abe K, Fujikawa H, Horiuchi T, Nagai K, et al. Vanishing bile duct syndrome associated with chronic EBV infection. Dig Dis Sci 2000;45:160-5.
34. Larroche C, Mouthon L. Pathogenesis of hemophagocytic syndrome (HPS). Autoimmun Rev 2004;3:69-75.
35. Emmenegger U, Schaer DJ, Larroche C, Neftel KA. Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Med Wkly 2005;135:299-314.
36. Verbsky JW, Grossman WJ. Hemophagocytic lymphohistiocytosis: diagnosis, pathophysiology, treatment, and future perspectives. Ann Med 2006;38:20-31.
37. Jordan MB, Hildeman D, Kappler J, Marrack P. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder. Blood 2004;104:735-43.
38. Hasegawa D, Kojima S, Tatsumi E, Hayakawa A, Kosaka Y, Nakamura H, et al. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia. Blood 1998;91:2793-9.
39. Billiau AD, Roskams T, Van Damme-Lombaerts R, Matthys P, Wouters C. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. Blood 2005;105:1648-51.
40. Ding WX, Yin XM. Dissection of the multiple mechanisms of TNF-alpha-induced apoptosis in liver injury. J Cell Mol Med 2004;8:445-54.
41. Schaer DJ, Schleiffenbaum B, Kurrer M, Imhof A, Bachli E, Fehr J, et al. Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 2005;74:6-10.
42. Hiraoka A, Horiike N, Akbar SM, Michitaka K, Matsuyama T, Onji M. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure. J Gastroenterol 2005;40:52-6.
43. Takada H, Ohga S, Mizuno Y, Suminoe A, Matsuzaki A, Ihara K, et al. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: a novel marker of disease activity. Br J Haematol 1999;106:182-9.
44. Mazodier K, Marin V, Novick D, Farnarier C, Robitail S, Schleinitz N, et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005;106:3483-9.
45. Finotto S, Siebler J, Hausding M, Schipp M, Wirtz S, Klein S, et al. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 2004;53:392-400.
46. Takahashi N, Chubachi A, Kume M, Hatano Y, Komatsuda A, Kawabata Y, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases. Int J Hematol 2001;74:209-13.
47. Imashuku S, Kuriyama K, Sakai R, Nakao Y, Masuda S, Yasuda N, et al. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Med Pediatr Oncol 2003;41:103-9.
48. Janka GE. Familial hemophagocytic lymphohistiocytosis. Eur J Pediatr 1983;140:221-30.
49. Imashuku S, Hyakuna N, Funabiki T, Ikuta K, Sako M, Iwai A, et al. Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with hemophagocytic lymphohistiocytosis. Cancer 2002;94:3023-31.
50. Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, et al. Histocyte Society. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 2002;100:2367-73.
51. Larroche C, Bruneel F, Andre MH, Bader-Meunier B, Baruchel A, Tribout B, et al. Comite d'Evaluation et de Diffusion des Innovation Technologiques (CEDIT). Les immunoglobulines intra-veineuses dans les syndromes d'activation macrophagique secondaires. Étude multicentrique évaluant leur intérêt, pour le groupe d'experts sur les immunoglobulines du CEDIT de l'AP-HP. Ann Med Interne (Paris) 2000;151:533-9.
52. Emmenegger U, Frey U, Reimers A, Fux C, Semela D, Cottagnoud P, et al. Hyperferritinemia as indicator for intravenous immunoglobulin treatment in reactive macrophage activation syndromes. Am J Hematol 2001;68:4-10.
53. Coman T, Dalloz MA, Coolen N, Heshmati F, Pene F, Cariou A, et al. Plasmapheresis for the treatment of acute pancreatitis induced by hemophagocytic syndrome related to hypertriglyceridemia. J Clin Apher 2003;18:129-31.
54. Matsumoto Y, Naniwa D, Banno S, Sugiura Y. The efficacy of therapeutic plasmapheresis for the treatment of fatal hemophagocytic syndrome: two case reports. Ther Apher 1998;2:300-4.
55. Kodama K, Kuno H, Koide M, Matsuo T. Virus-associated haemophagocytic syndrome responsive to steroid pulse therapy and double filtration plasmapheresis. Clin Lab Haematol 2000;22:179-81.